Biortica Agrimed takeover target, Bod Science, has sold a trio of intellectual property (IP) rights, including […]
Gibraltar-Based Firm Acquires Bod Science's Low-Dose CBD Trial Data and IP Assets
The Cannabis Observer
·
FOUNDING MEMBERS
First 100 readers lock in 50% off for life
Sector coverage written for operators, not tourists. Reserve founding-member pricing before launch.
- Weekday briefings on regulation, access schemes, and the companies shaping the market
- Full archive and weekly deep-dives once premium goes live
- 50% off the launch price, locked in for as long as your subscription stays active
Join 87 readers already on the waitlist
Aqua Phase
Biortica Agrimed
Bod Science
CBD clinical trial
Gregory Stoloff
low dose CBD
Optimus Salvus
Peter Stabler
Related Articles
